Further theoretical insight into the reaction mechanism of the hepatitis C NS3/NS4A serine protease

被引:1
|
作者
Angel Martinez-Gonzalez, Jose [1 ]
Rodriguez, Alex [2 ]
Pilar Puyuelo, Maria [1 ]
Gonzalez, Miguel [3 ]
Martinez, Rodrigo [1 ]
机构
[1] Univ La Rioja, Dept Quim, Logrono 26006, Spain
[2] SISSA, I-34136 Trieste, Italy
[3] Univ Barcelona, Dept Quim Fis & IQTC, E-08028 Barcelona, Spain
关键词
QUANTUM MECHANICS/MOLECULAR MECHANICS; VIRUS NS3 PROTEASE; CRYSTAL-STRUCTURE; THERAPIES; ENZYMES;
D O I
10.1016/j.cplett.2014.11.041
中图分类号
O64 [物理化学(理论化学)、化学物理学];
学科分类号
070304 ; 081704 ;
摘要
The main reactions of the hepatitis C virus NS3/NS4A serine protease are studied using the secondorder Moller-Plesset ab initio method and rather large basis sets to correct the previously reported A1VI1/CHARMM22 potential energy surfaces. The reaction efficiencies measured for the different substrates are explained in terms of the tetrahedral intermediate formation step (the rate-limiting process). The energies of the barrier and the corresponding intermediate are so close that the possibility of a concerted mechanism is open (especially for the NS5A/5B substrate). This is in contrast to the suggested general reaction mechanism of serine proteases, where a two-step mechanism is postulated. (C) 2014 Elsevier B.V. All rights reserved.
引用
收藏
页码:97 / 102
页数:6
相关论文
共 50 条
  • [41] Hepatitis C virus NS3/4a protease inhibitors
    McCauley, John A.
    Rudd, Michael T.
    CURRENT OPINION IN PHARMACOLOGY, 2016, 30 : 84 - 92
  • [42] Bismacrocyclic Inhibitors of Hepatitis C NS3/4a Protease
    McCauley, John A.
    Rudd, Michael T.
    Nguyen, Kevin T.
    McIntyre, Charles J.
    Romano, Joseph J.
    Bush, Kimberly J.
    Varga, Sandor L.
    Ross, Charles W., III
    Carroll, Steven S.
    DiMuzio, Jillian
    Stahlhut, Mark W.
    Olsen, David B.
    Lyle, Terry A.
    Vacca, Joseph P.
    Liverton, Nigel J.
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (47) : 9104 - 9107
  • [43] Telaprevir: A Hepatitis C NS3/4A Protease Inhibitor
    Matthews, Samuel James
    Lancaster, Jason W.
    CLINICAL THERAPEUTICS, 2012, 34 (09) : 1857 - 1882
  • [44] Prime site binding inhibitors of a serine protease:: NS3/4A of hepatitis C virus
    Ingallinella, P
    Fattori, D
    Altamura, S
    Steinkühler, C
    Koch, U
    Cicero, D
    Bazzo, R
    Cortese, R
    Bianchi, E
    Pessi, A
    BIOCHEMISTRY, 2002, 41 (17) : 5483 - 5492
  • [45] Serine protease of hepatitis C virus expressed in insect cells as the NS3/4A complex
    Sali, DL
    Ingram, R
    Wendel, M
    Gupta, D
    McNemar, C
    Tsarbopoulos, A
    Chen, JW
    Hong, Z
    Chase, R
    Risano, C
    Zhang, RM
    Yao, NH
    Kwong, AD
    Ramanathan, L
    Le, HV
    Weber, PC
    BIOCHEMISTRY, 1998, 37 (10) : 3392 - 3401
  • [46] Hepatitis C virus NS3 serine protease interacts with the serpin Cl inhibitor
    Drouet, C
    Bouillet, L
    Csopaki, F
    Colomb, MG
    FEBS LETTERS, 1999, 458 (03) : 415 - 418
  • [47] Sequential Phosphorylation of the Hepatitis C Virus NS5A Protein Depends on NS3-Mediated Autocleavage between NS3 and NS4A
    Chiang, Cho-Han
    Lai, Yen-Ling
    Huang, Yu-Ning
    Yu, Chun-Chiao
    Lu, Christine C.
    Yu, Guann-Yi
    Yu, Ming-Jiun
    JOURNAL OF VIROLOGY, 2020, 94 (19)
  • [48] Genetic screen for monitoring hepatitis C virus NS3 serine protease activity
    Martinez, MA
    Clotet, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2003, 47 (05) : 1760 - 1765
  • [49] ASUNAPREVIR HCV Serine Protease NS3 Inhibitor Treatment of Hepatitis C Virus
    Reviriego, C.
    DRUGS OF THE FUTURE, 2012, 37 (04) : 247 - 254
  • [50] The N-terminal helix α0 of hepatitis C virus NS3 protein dictates the subcellular localization and stability of NS3/NS4A complex
    He, Ying
    Weng, Leiyun
    Li, Rui
    Li, Li
    Toyoda, Tetsuya
    Zhong, Jin
    VIROLOGY, 2012, 422 (02) : 214 - 223